Mitsubishi Tanabe Pharma

Results: 77



#Item
71February, 3, 2014 Press Release Mitsubishi Tanabe Pharma Corporation MT-4666 in Alzheimer’s Disease Start of Global Phase 3 Clinical Trial Program, COGNITIV AD

February, 3, 2014 Press Release Mitsubishi Tanabe Pharma Corporation MT-4666 in Alzheimer’s Disease Start of Global Phase 3 Clinical Trial Program, COGNITIV AD

Add to Reading List

Source URL: www.mt-pharma.co.jp

Language: English - Date: 2014-02-02 22:14:03
72October 10, 2012 Press release Mitsubishi Tanabe Pharma Corporation KUREHA CORPORATION  Outcome of Global Phase III (EPPIC) Studies

October 10, 2012 Press release Mitsubishi Tanabe Pharma Corporation KUREHA CORPORATION Outcome of Global Phase III (EPPIC) Studies

Add to Reading List

Source URL: www.mt-pharma.co.jp

Language: English - Date: 2012-10-10 01:16:29
73May 8, 2012 For immediate release: Japanese Red Cross Society Mitsubishi Tanabe Pharma Corporation  New Organization in Plasma Fractionation Operations

May 8, 2012 For immediate release: Japanese Red Cross Society Mitsubishi Tanabe Pharma Corporation New Organization in Plasma Fractionation Operations

Add to Reading List

Source URL: www.mt-pharma.co.jp

Language: English - Date: 2012-05-07 06:53:37
74April 30, 2013 Mitsubishi Tanabe Pharma Corporation Change of Directors Osaka, Japan, April 30, [removed]Today, Mitsubishi Tanabe Pharma Corporation (President & Representative Director, CEO, Michihiro Tsuchiya) announc

April 30, 2013 Mitsubishi Tanabe Pharma Corporation Change of Directors Osaka, Japan, April 30, [removed]Today, Mitsubishi Tanabe Pharma Corporation (President & Representative Director, CEO, Michihiro Tsuchiya) announc

Add to Reading List

Source URL: www.mt-pharma.co.jp

Language: English - Date: 2013-04-26 06:10:12
75July 4, 2014 Press release: Mitsubishi Tanabe Pharma Corporation Daiichi Sankyo Co., Ltd.  Marketing and Manufacturing Approval in Japan Received for

July 4, 2014 Press release: Mitsubishi Tanabe Pharma Corporation Daiichi Sankyo Co., Ltd. Marketing and Manufacturing Approval in Japan Received for

Add to Reading List

Source URL: www.mt-pharma.co.jp

Language: English - Date: 2014-07-04 01:18:30
76July 23, 2012 Press Release Mitsubishi Tanabe Pharma Corporation Launch of Tranquilizer, DEPAS® TABLETS 0.25 mg

July 23, 2012 Press Release Mitsubishi Tanabe Pharma Corporation Launch of Tranquilizer, DEPAS® TABLETS 0.25 mg

Add to Reading List

Source URL: www.mt-pharma.co.jp

Language: English - Date: 2012-07-22 12:08:56
77August 31, 2012 Press Release: Mitsubishi Tanabe Pharma Corporation Notice regarding dissolution of Bipha Corporation-related joint venture with Nipro Corporation Osaka, Japan, August 31, 2012--Mitsubishi Tanabe Pharma C

August 31, 2012 Press Release: Mitsubishi Tanabe Pharma Corporation Notice regarding dissolution of Bipha Corporation-related joint venture with Nipro Corporation Osaka, Japan, August 31, 2012--Mitsubishi Tanabe Pharma C

Add to Reading List

Source URL: www.mt-pharma.co.jp

Language: English - Date: 2012-08-31 01:26:02